Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2019
Date Filed: August 30, 2019
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves to incorporate by reference the "Appendix 4G & Corporate governance statement 2019" into the company's Registration Statements on Form S-8 and Form F-3.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to update corporate governance disclosures rather than a financial results report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this text. The filing focuses on the submission of the 2019 Corporate Governance Statement.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on operations, or a discussion of risks and contingencies. The primary content is the reference to the corporate governance statement.
Key Facts for Investor Verification
- Verify the contents of the "Appendix 4G & Corporate governance statement 2019" referenced in Item 99.1, as the full text is not included in this filing.
- Confirm the status of the Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417) into which this report is incorporated.
- Note that this filing does not contain financial performance data for August 2019.